Skip to main content
. 2021 Sep 21;11(19):9538–9556. doi: 10.7150/thno.55954

Figure 1.

Figure 1

The role of ex vivo chemosensitivity and chemoresistance assays (CSRA) in cancer care, a virtuous cycle. Such assays use qualified patient samples and primary culture technologies to directly test the activity of relevant anticancer drugs on a patient's own tumour cells. The resulting chemosensitivity profile is usable by physicians to fine-tune treatments.